Back To TOP

We Focus on Access so
You Can Focus on Health

Connecting your patients to KADCYLA®
(ado-trastuzumab emtansine).
Welcome to KADCYLA Access Solutions.

I am a
Learn More About
KADCYLA
  • LEARN about treatment with KADCYLA
  • NEW Permanent J-code Effective
    January 1, 2014
  • LEARN HOW the Genentech BioOncology Co-pay Card can help with the out-of-pocket costs for KADCYLA
  • Download: new forms for enrollment in GATCF
  • Form Statement of Medical Necessity
  • Form Patient Authorization and Notice of Release of Information

The Access Solutions logo is a registered trademark of Genentech, Inc.